Free Trial

Organon & Co. (OGN) Competitors

Organon & Co. logo
$9.04 +0.11 (+1.17%)
Closing price 03:59 PM Eastern
Extended Trading
$9.01 -0.04 (-0.39%)
As of 06:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

OGN vs. ELAN, VRNA, RVMD, RGC, ABVX, MRUS, RNA, CYTK, RYTM, and GRFS

Should you be buying Organon & Co. stock or one of its competitors? The main competitors of Organon & Co. include Elanco Animal Health (ELAN), Verona Pharma PLC American Depositary Share (VRNA), Revolution Medicines (RVMD), Regencell Bioscience (RGC), Abivax (ABVX), Merus (MRUS), Avidity Biosciences (RNA), Cytokinetics (CYTK), Rhythm Pharmaceuticals (RYTM), and Grifols (GRFS). These companies are all part of the "pharmaceutical products" industry.

Organon & Co. vs. Its Competitors

Organon & Co. (NYSE:OGN) and Elanco Animal Health (NYSE:ELAN) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, media sentiment, earnings, risk and valuation.

Organon & Co. has a net margin of 11.15% compared to Elanco Animal Health's net margin of 9.68%. Organon & Co.'s return on equity of 163.88% beat Elanco Animal Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Organon & Co.11.15% 163.88% 6.99%
Elanco Animal Health 9.68%7.04%3.45%

Organon & Co. currently has a consensus target price of $17.33, indicating a potential upside of 91.63%. Elanco Animal Health has a consensus target price of $20.00, indicating a potential downside of 8.13%. Given Organon & Co.'s higher probable upside, analysts plainly believe Organon & Co. is more favorable than Elanco Animal Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Organon & Co.
1 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
2.50
Elanco Animal Health
0 Sell rating(s)
3 Hold rating(s)
6 Buy rating(s)
2 Strong Buy rating(s)
2.91

77.4% of Organon & Co. shares are owned by institutional investors. Comparatively, 97.5% of Elanco Animal Health shares are owned by institutional investors. 2.0% of Organon & Co. shares are owned by company insiders. Comparatively, 0.9% of Elanco Animal Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Elanco Animal Health had 5 more articles in the media than Organon & Co.. MarketBeat recorded 11 mentions for Elanco Animal Health and 6 mentions for Organon & Co.. Organon & Co.'s average media sentiment score of 1.01 beat Elanco Animal Health's score of 0.83 indicating that Organon & Co. is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Organon & Co.
4 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Positive
Elanco Animal Health
7 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Organon & Co. has higher revenue and earnings than Elanco Animal Health. Organon & Co. is trading at a lower price-to-earnings ratio than Elanco Animal Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Organon & Co.$6.40B0.37$864M$2.693.36
Elanco Animal Health$4.44B2.44$338M$0.8625.31

Organon & Co. has a beta of 0.63, suggesting that its share price is 37% less volatile than the S&P 500. Comparatively, Elanco Animal Health has a beta of 1.65, suggesting that its share price is 65% more volatile than the S&P 500.

Summary

Organon & Co. beats Elanco Animal Health on 9 of the 17 factors compared between the two stocks.

Get Organon & Co. News Delivered to You Automatically

Sign up to receive the latest news and ratings for OGN and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OGN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OGN vs. The Competition

MetricOrganon & Co.Medical Services IndustryMedical SectorNYSE Exchange
Market Cap$2.32B$8.42B$6.19B$21.90B
Dividend Yield0.89%2.11%5.72%3.59%
P/E Ratio3.3677.7529.6432.78
Price / Sales0.3740.78577.4660.02
Price / Cash1.8121.1336.5524.20
Price / Book4.947.1812.074.65
Net Income$864M$250.93M$3.32B$1.01B
7 Day Performance-3.57%0.35%-0.16%1.48%
1 Month Performance-14.39%-1.96%5.76%0.43%
1 Year Performance-47.44%14.71%65.71%12.71%

Organon & Co. Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OGN
Organon & Co.
4.8864 of 5 stars
$9.05
+1.2%
$17.33
+91.6%
-48.5%$2.32B$6.40B3.364,000News Coverage
Positive News
Upcoming Earnings
ELAN
Elanco Animal Health
2.4471 of 5 stars
$20.04
+1.4%
$19.14
-4.5%
+70.9%$9.96B$4.48B23.309,000Analyst Forecast
VRNA
Verona Pharma PLC American Depositary Share
1.0908 of 5 stars
$106.91
flat
$109.00
+2.0%
N/A$9.21B$42.28M-107.9930Positive News
RVMD
Revolution Medicines
4.3003 of 5 stars
$48.75
+1.1%
$74.64
+53.1%
+12.4%$9.11BN/A-10.83250News Coverage
Analyst Upgrade
RGC
Regencell Bioscience
0.6962 of 5 stars
$17.99
+7.0%
N/AN/A$8.90BN/A0.0010
ABVX
Abivax
3.3755 of 5 stars
$95.63
+2.0%
$114.25
+19.5%
+763.9%$7.23BN/A0.0061Short Interest ↓
MRUS
Merus
1.7392 of 5 stars
$94.85
+0.5%
$93.12
-1.8%
+77.5%$7.17B$56.23M-17.2537Upcoming Earnings
Short Interest ↓
RNA
Avidity Biosciences
2.6313 of 5 stars
$48.96
-1.6%
$68.32
+39.5%
-1.1%$7.14B$10.90M-13.75190
CYTK
Cytokinetics
3.8776 of 5 stars
$59.59
-0.7%
$76.64
+28.6%
-0.3%$7.13B$85.74M-11.68250Trending News
Analyst Forecast
Insider Trade
RYTM
Rhythm Pharmaceuticals
3.0217 of 5 stars
$100.77
0.0%
$106.64
+5.8%
+122.2%$6.69B$156.29M-33.48140Insider Trade
GRFS
Grifols
3.446 of 5 stars
$9.45
+1.4%
$10.30
+9.0%
+8.3%$6.50B$7.81B8.0823,822

Related Companies and Tools


This page (NYSE:OGN) was last updated on 10/23/2025 by MarketBeat.com Staff
From Our Partners